Jin-Wu-Jian-Gu Formulation Attenuates Rheumatoid Arthritis by Inhibiting the IL33-ST2 Signaling Pathway

Figure 1

Analysis of key components and core targets of JWJGF therapy for RA based on network pharmacology. (a) Venn diagram of overlapped gene between JWJGF and RA targets. (b) JWJGF-compound-target-RA network diagram. Blue diamonds represented candidate targets of JWJGF against RA, and circular and hexagon shapes represented active ingredients of JWJGF.

(a)

(b)